StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

ENDRA Life Sciences's gross profit for the twelve months ending Dec 31, 2019 was $0, down 100.0% year over year. For fiscal 2020 it was $0. The highest annual figure on record is $279.70K in fiscal 2016.

Annual gross profit

PeriodPeriod endValueChange
FY2020Dec 31, 2020$0–
FY2019Dec 31, 2019$0-100.0%
FY2018Dec 31, 2018$6.17K-96.5%
FY2017Dec 31, 2017$178.84K-36.1%
FY2016Dec 31, 2016$279.70K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$0-100.0%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$0-100.0%
Q2 FY2018Jun 30, 2018$0-100.0%
Q1 FY2018Mar 31, 2018$6.17K–
Q4 FY2017Dec 31, 2017$3.77K-98.7%
Q3 FY2017Sep 30, 2017$168.73K–
Q2 FY2017Jun 30, 2017$6.35K–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$279.70K–
Q3 FY2016Sep 30, 2016$0–

More ENDRA Life Sciences figures

See a number that looks wrong?